Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
08 Jun 2015 Liver-Directed Therapy With SIRT, Using Y-90 Resin Microspheres, Plus FOLFOX-Based First-Line Chemotherapy for mCRC Gastrointestinal cancers
18 May 2015 Annals of Oncology Press Release: World First – Researchers Quantify the Proportion of Different Genetic Mutations Contained within Individual Bowel Cancers Gastrointestinal cancers
27 Apr 2015 FDA Approves Ramucirumab for Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
31 Mar 2015 Clinicians Hail Benefits of ESMO Clinical Practice Guidelines Gastrointestinal cancers
05 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
04 Mar 2015 Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas Translational research - Gastrointestinal cancers
16 Feb 2015 Estimates of Gastric, Breast Cancer Risk in CDH1 Gene Mutation Carriers Breast cancer - Cancer in Special Situations - Gastrointestinal cancers
28 Jan 2015 Withdrawal of the Application for a Change to the Marketing Authorisation for Tegafur/Gimeracil/Oteracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
22 Jan 2015 Successful Implementation of SPECTAcolor, the First Pan-European and EORTC Screening Platform, Proves that a Logistically Complex Infrastructure to Run Next Generation Trials in a Multinational Setting is Feasible Personalised medicine - Translational research - Gastrointestinal cancers
20 Jan 2015 First-Line FOLFOXIRI/Bevacizumab Improves Long-Term Outcomes in Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
19 Jan 2015 Second-Line Treatment with FOLFIRI/Ramucirumab Delays Disease Progression and Extends Overall Survival in Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
26 Nov 2014 Dual or Triple Inhibition May be Better Than Monotherapy in Patients With BRAF-mutated Advanced Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 Nov 2014 Young Patients With Newly Diagnosed Colorectal Cancer Anticipated to Nearly Double by 2030 Epidemiology/Etiology/Cancer Prevention - Cancer in Special Situations - Gastrointestinal cancers
29 Sep 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Ramucirumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: TAS-102 Improves Overall- and Progression-Free Survival in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies Gastrointestinal cancers - Anticancer agents & Biologic therapy